GLYCOLAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glycolax, and when can generic versions of Glycolax launch?
Glycolax is a drug marketed by Lannett Co Inc and is included in two NDAs.
The generic ingredient in GLYCOLAX is polyethylene glycol 3350. There are four hundred and twenty-one drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glycolax
A generic version of GLYCOLAX was approved as polyethylene glycol 3350 by MYLAN on October 6th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLYCOLAX?
- What are the global sales for GLYCOLAX?
- What is Average Wholesale Price for GLYCOLAX?
Summary for GLYCOLAX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Clinical Trials: | 2 |
| DailyMed Link: | GLYCOLAX at DailyMed |
Recent Clinical Trials for GLYCOLAX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Massachusetts General Hospital | Phase 3 |
| AstraZeneca | Phase 3 |
| Temple University | Phase 4 |
US Patents and Regulatory Information for GLYCOLAX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | GLYCOLAX | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 076652-001 | Jul 2, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett Co Inc | GLYCOLAX | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 090600-001 | Oct 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett Co Inc | GLYCOLAX | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 090600-002 | Oct 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
